Ironwood Pharmaceuticals Stock Forecast - Treynor Ratio
IRWD Stock | USD 3.34 0.18 5.11% |
Ironwood Stock Forecast is based on your current time horizon. Investors can use this forecasting interface to forecast Ironwood Pharmaceuticals stock prices and determine the direction of Ironwood Pharmaceuticals's future trends based on various well-known forecasting models. We recommend always using this module together with an analysis of Ironwood Pharmaceuticals' historical fundamentals, such as revenue growth or operating cash flow patterns.
Ironwood |
Check Ironwood Pharmaceuticals Volatility | Backtest Ironwood Pharmaceuticals | Information Ratio |
Ironwood Pharmaceuticals Trading Date Momentum
On November 22 2024 Ironwood Pharmaceuticals was traded for 3.34 at the closing time. The top price for the day was 3.74 and the lowest listed price was 3.31 . There was no trading activity during the period 0.0. Lack of trading volume on November 22, 2024 did not cause price change. The trading delta at closing time against the current closing price is 5.69% . |
Compare Ironwood Pharmaceuticals to competition |
Other Forecasting Options for Ironwood Pharmaceuticals
For every potential investor in Ironwood, whether a beginner or expert, Ironwood Pharmaceuticals' price movement is the inherent factor that sparks whether it is viable to invest in it or hold it better. Ironwood Stock price charts are filled with many 'noises.' These noises can hugely alter the decision one can make regarding investing in Ironwood. Basic forecasting techniques help filter out the noise by identifying Ironwood Pharmaceuticals' price trends.Ironwood Pharmaceuticals Related Equities
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Ironwood Pharmaceuticals stock to make a market-neutral strategy. Peer analysis of Ironwood Pharmaceuticals could also be used in its relative valuation, which is a method of valuing Ironwood Pharmaceuticals by comparing valuation metrics with similar companies.
Risk & Return | Correlation |
Ironwood Pharmaceuticals Technical and Predictive Analytics
The stock market is financially volatile. Despite the volatility, there exist limitless possibilities of gaining profits and building passive income portfolios. With the complexity of Ironwood Pharmaceuticals' price movements, a comprehensive understanding of forecasting methods that an investor can rely on to make the right move is invaluable. These methods predict trends that assist an investor in predicting the movement of Ironwood Pharmaceuticals' current price.Cycle Indicators | ||
Math Operators | ||
Math Transform | ||
Momentum Indicators | ||
Overlap Studies | ||
Pattern Recognition | ||
Price Transform | ||
Statistic Functions | ||
Volatility Indicators | ||
Volume Indicators |
Ironwood Pharmaceuticals Market Strength Events
Market strength indicators help investors to evaluate how Ironwood Pharmaceuticals stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Ironwood Pharmaceuticals shares will generate the highest return on investment. By undertsting and applying Ironwood Pharmaceuticals stock market strength indicators, traders can identify Ironwood Pharmaceuticals entry and exit signals to maximize returns.
Ironwood Pharmaceuticals Risk Indicators
The analysis of Ironwood Pharmaceuticals' basic risk indicators is one of the essential steps in accurately forecasting its future price. The process involves identifying the amount of risk involved in Ironwood Pharmaceuticals' investment and either accepting that risk or mitigating it. Along with some essential techniques for forecasting ironwood stock prices, we also provide a set of basic risk indicators that can assist in the individual investment decision or help in hedging the risk of your existing portfolios.
Mean Deviation | 3.42 | |||
Standard Deviation | 4.41 | |||
Variance | 19.44 |
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential investments, we recommend comparing similar equities with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.When determining whether Ironwood Pharmaceuticals is a strong investment it is important to analyze Ironwood Pharmaceuticals' competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Ironwood Pharmaceuticals' future performance. For an informed investment choice regarding Ironwood Stock, refer to the following important reports:Check out Historical Fundamental Analysis of Ironwood Pharmaceuticals to cross-verify your projections. For information on how to trade Ironwood Stock refer to our How to Trade Ironwood Stock guide.You can also try the Cryptocurrency Center module to build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Ironwood Pharmaceuticals. If investors know Ironwood will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Ironwood Pharmaceuticals listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth (0.77) | Earnings Share (0.01) | Revenue Per Share 2.393 | Quarterly Revenue Growth (0.20) | Return On Assets 0.1305 |
The market value of Ironwood Pharmaceuticals is measured differently than its book value, which is the value of Ironwood that is recorded on the company's balance sheet. Investors also form their own opinion of Ironwood Pharmaceuticals' value that differs from its market value or its book value, called intrinsic value, which is Ironwood Pharmaceuticals' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Ironwood Pharmaceuticals' market value can be influenced by many factors that don't directly affect Ironwood Pharmaceuticals' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Ironwood Pharmaceuticals' value and its price as these two are different measures arrived at by different means. Investors typically determine if Ironwood Pharmaceuticals is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Ironwood Pharmaceuticals' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.